Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas

Research output: Contribution to journalArticle

Standard

Time dependence of prognostic factors for patients with soft tissue sarcoma : a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. / Engellau, Jacob; Anderson, Harald; Rydholm, Anders; Bauer, Henrik C F; Hall, Kirsten Sundby; Gustafson, Pelle; Åkerman, Måns; Meis-Kindblom, Jeanne; Alvegård, Thor; Nilbert, Mef.

In: Cancer, Vol. 100, No. 10, 2004, p. 2233-2239.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Time dependence of prognostic factors for patients with soft tissue sarcoma

T2 - a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas

AU - Engellau, Jacob

AU - Anderson, Harald

AU - Rydholm, Anders

AU - Bauer, Henrik C F

AU - Hall, Kirsten Sundby

AU - Gustafson, Pelle

AU - Åkerman, Måns

AU - Meis-Kindblom, Jeanne

AU - Alvegård, Thor

AU - Nilbert, Mef

PY - 2004

Y1 - 2004

N2 - BACKGROUND: Prognostic factors for metastasis in soft tissue sarcoma govern decisions regarding adjuvant treatment. However, the significance of initial tumor-related prognostic factors over time is largely unknown.METHODS: The current study included 338 patients with malignant fibrous histiocytoma (MFH) of the extremities or the trunk wall whose tumors were reviewed by the Scandinavian Sarcoma Pathology Review Group. Of these 338 patients, 329 (97%) had high-grade tumors. The median follow-up period was 7 years. Metastases occurred in 110 of 338 of patients after a median follow-up period of 14 months, with roughly one-third (32 of 110) occurring after 2 years. The authors investigated the prognostic significance of tumor size, tumor depth, histologic grade, microscopic tumor necrosis, vascular invasion, mitotic rate, and local tumor recurrence at various time intervals using metastases as an endpoint.RESULTS: On univariate analysis, all investigated factors were found to be correlated with metastases for the entire follow-up period and also for the first 2 years of follow-up; beyond this time point, only size, tumor depth, and local recurrence were significant. On multivariate analysis, necrosis and local tumor recurrence were significant for the entire follow-up duration and also for the first 2 years of follow-up, whereas only tumor depth and local recurrence were significant beyond 2 years of follow-up. For all initial factors, the annual metastasis risks in the high-risk and low-risk groups converged to < 0.1 after 2 years and to near 0 after 5 years.CONCLUSIONS: Prognostic factors for metastasis in MFH were time dependent. The predictive value of the initial prognostic factors was limited to the first 2 years of follow-up. The lack of observed prognostic value beyond 2 years of follow-up probably was attributable to heterogeneity within risk categories as a result of measurement errors and unknown biologic variations.

AB - BACKGROUND: Prognostic factors for metastasis in soft tissue sarcoma govern decisions regarding adjuvant treatment. However, the significance of initial tumor-related prognostic factors over time is largely unknown.METHODS: The current study included 338 patients with malignant fibrous histiocytoma (MFH) of the extremities or the trunk wall whose tumors were reviewed by the Scandinavian Sarcoma Pathology Review Group. Of these 338 patients, 329 (97%) had high-grade tumors. The median follow-up period was 7 years. Metastases occurred in 110 of 338 of patients after a median follow-up period of 14 months, with roughly one-third (32 of 110) occurring after 2 years. The authors investigated the prognostic significance of tumor size, tumor depth, histologic grade, microscopic tumor necrosis, vascular invasion, mitotic rate, and local tumor recurrence at various time intervals using metastases as an endpoint.RESULTS: On univariate analysis, all investigated factors were found to be correlated with metastases for the entire follow-up period and also for the first 2 years of follow-up; beyond this time point, only size, tumor depth, and local recurrence were significant. On multivariate analysis, necrosis and local tumor recurrence were significant for the entire follow-up duration and also for the first 2 years of follow-up, whereas only tumor depth and local recurrence were significant beyond 2 years of follow-up. For all initial factors, the annual metastasis risks in the high-risk and low-risk groups converged to < 0.1 after 2 years and to near 0 after 5 years.CONCLUSIONS: Prognostic factors for metastasis in MFH were time dependent. The predictive value of the initial prognostic factors was limited to the first 2 years of follow-up. The lack of observed prognostic value beyond 2 years of follow-up probably was attributable to heterogeneity within risk categories as a result of measurement errors and unknown biologic variations.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Extremities

KW - Female

KW - Histiocytoma, Benign Fibrous/pathology

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Mitotic Index

KW - Neoplasm Invasiveness/pathology

KW - Neoplasm Recurrence, Local/pathology

KW - Prognosis

KW - Risk Factors

KW - Sarcoma/pathology

KW - Survival Rate

KW - Time Factors

U2 - 10.1002/cncr.20254

DO - 10.1002/cncr.20254

M3 - Article

C2 - 15139069

VL - 100

SP - 2233

EP - 2239

JO - Cancer

JF - Cancer

SN - 1097-0142

IS - 10

ER -